{
    "company_name": "Incyte Corporation",
    "file_name": "4d3e52b69b4b5366e54ce87cf641b01b1419bdee",
    "data_points": [
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of drugs on the market (approved)",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase I",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase III",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Global distribution network (markets served)",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Pharmacovigilance reports (adverse events logged)",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Branded product count",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Generic product count",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of active pharmaceutical patents",
            "metric_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of drugs on the market (approved)",
            "metric_src_pdf_page": [
                109,
                110,
                119,
                130
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase I",
            "metric_src_pdf_page": [
                109,
                110,
                113
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                110,
                113,
                119
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (liters/year)",
            "metric_src_pdf_page": [
                109,
                110,
                119
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                109,
                110,
                111,
                112
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Size of sales force (year-end)",
            "metric_src_pdf_page": [
                111,
                112
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of active pharmaceutical patents",
            "metric_src_pdf_page": [
                118
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Global distribution network (markets served)",
            "metric_src_pdf_page": [
                110,
                111
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Inventory of active pharmaceutical ingredients",
            "metric_src_pdf_page": [
                112,
                114
            ]
        },
        {
            "company_name": "Incyte Corporation",
            "industry": "Pharmaceuticals",
            "metric_type": "Pharmacovigilance reports (adverse events logged)",
            "metric_src_pdf_page": [
                111,
                114
            ]
        }
    ],
    "events": [
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "event_type": "has_guidance_updates",
            "events_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "event_type": "has_strategic_restructuring",
            "events_src_pdf_page": [
                8,
                10,
                12,
                14,
                17,
                22,
                25,
                32,
                49,
                51,
                70,
                72,
                94,
                95,
                97
            ]
        },
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                106,
                107,
                111,
                113
            ]
        },
        {
            "event_type": "has_leadership_changes",
            "events_src_pdf_page": [
                107,
                113,
                115
            ]
        },
        {
            "event_type": "has_strategic_restructuring",
            "events_src_pdf_page": [
                115,
                117
            ]
        },
        {
            "event_type": "has_rnd_investment_numbers",
            "events_src_pdf_page": [
                108,
                110,
                117
            ]
        },
        {
            "event_type": "has_guidance_updates",
            "events_src_pdf_page": [
                111,
                115
            ]
        }
    ],
    "fin_metrics": [
        {
            "fin_metric_type": "total revenue",
            "fin_metrics_src_pdf_page": [
                85,
                86,
                88,
                89,
                90,
                91,
                92
            ]
        },
        {
            "fin_metric_type": "net profit margin",
            "fin_metrics_src_pdf_page": [
                110,
                111
            ]
        },
        {
            "fin_metric_type": "total revenue",
            "fin_metrics_src_pdf_page": [
                110,
                111
            ]
        },
        {
            "fin_metric_type": "operating income",
            "fin_metrics_src_pdf_page": [
                111,
                119
            ]
        },
        {
            "fin_metric_type": "gross profit margin",
            "fin_metrics_src_pdf_page": [
                117,
                118
            ]
        },
        {
            "fin_metric_type": "research and development expenses",
            "fin_metrics_src_pdf_page": [
                110,
                111,
                115
            ]
        }
    ]
}